Ranbaxy Laboratories issues NCD worth Rs 500 crore

24 Nov 2012 Evaluate

Ranbaxy Laboratories has issued 5,000 secured 9.20% Redeemable Non-Convertible Debentures (NCD) of face value of Rs 10,00,000 each, for cash at par, aggregating Rs 500 crore, on a private placement basis, for general corporate purposes. These debentures have been rated AA+ by CARE and are proposed to be listed on stock National Exchange of India (NSE).

In another development, the company had recalled Atorvastatin from the USA market which will cause temporary disruption to the market of this product.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×